🇪🇺 Duloxetine hydrochloride - 60 mg in European Union

EMA authorised Duloxetine hydrochloride - 60 mg on 17 December 2004

Marketing authorisation

EMA — authorised 17 December 2004

  • Application: EMEA/H/C/000572
  • Marketing authorisation holder: Eli Lilly Nederland B.V.
  • Local brand name: Cymbalta
  • Indication: Treatment of major depressive disorder. Treatment of diabetic peripheral neuropathic pain. Treatment of generalised anxiety disorder. Cymbalta is indicated in adults.
  • Status: approved

Read official source →

Duloxetine hydrochloride - 60 mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Duloxetine hydrochloride - 60 mg approved in European Union?

Yes. EMA authorised it on 17 December 2004.

Who is the marketing authorisation holder for Duloxetine hydrochloride - 60 mg in European Union?

Eli Lilly Nederland B.V. holds the EU marketing authorisation.